Lowell Thomas Holden, CFO at Nascent Biotech Inc. (NBIO), bought 20,000 shares at $0.14 ($3K) on 2023-01-27, disclosed to the SEC on 2023-02-02.
Open-market purchase of $3k NBIO by CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| NBIO | SELL | 2022-07-25 | $1K | — | Filing → |
| SKKY | BUY | 2022-04-11 | $2K | — | Filing → |
| NBIO | BUY | 2020-01-06 | $850 | — | Filing → |